Project cooperationUpdated on 17 February 2025
Policapr – The Future of Personalized Medication Delivery
About
🚀 Executive Summary: Policapr – The Future of Personalized Medication Delivery
Problem & Market Need
Medication non-adherence leads to poor health outcomes, increased hospitalizations, and $500B in preventable healthcare costs. Patients with chronic diseases like cardiovascular conditions struggle to manage complex drug regimens, leading to missed doses, treatment failure, and reduced efficacy.
Solution: Policapr
Policapr combines multiple prescriptions into a single, personalized polypill using polymer-based drug release and automated compounding technology. This simplifies medication management, enhances adherence, and improves patient outcomes, offering a scalable, cost-effective, and transformative drug delivery solution.
Key Differentiation & Competitive Advantage
✅ Personalized, controlled drug release vs. traditional pill sorting
✅ Automated compounding for precision dosing and scalability
✅ Licensable technology for pharma integration and commercialization
✅ More cost-effective and scalable than 3D-printed medications or manual compounding
Similar opportunities
Service
Notified Body (EU) 2017/745 MDR
- Others
- Medtech
Vasily Kalakutskiy
Medical Product Certification Business Development Manager at SGS Germany GmbH
Puchheim, Germany
Service
Industry Specific Medical Software Solutions
- ICT
- Medtech
- Consulting
- Development
Tamás FODOR
Head of Software Development at Silurus Software Kft.
Budapest, Hungary
Service
Industry Specific Medical Software Solutions
- ICT
- Medtech
- Consulting
- Development
Péter TÖRÖK
Co-CEO at Silurus Software Kft.
Budapest, Hungary